314 related articles for article (PubMed ID: 34251580)
1. AI in drug development: a multidisciplinary perspective.
Gallego V; Naveiro R; Roca C; Ríos Insua D; Campillo NE
Mol Divers; 2021 Aug; 25(3):1461-1479. PubMed ID: 34251580
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science.
Saifi I; Bhat BA; Hamdani SS; Bhat UY; Lobato-Tapia CA; Mir MA; Dar TUH; Ganie SA
J Biomol Struct Dyn; 2024 Aug; 42(12):6523-6541. PubMed ID: 37434311
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
[TBL] [Abstract][Full Text] [Related]
4. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
Yang X; Wang Y; Byrne R; Schneider G; Yang S
Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
[TBL] [Abstract][Full Text] [Related]
5. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
6. Synergy between machine learning and natural products cheminformatics: Application to the lead discovery of anthraquinone derivatives.
Moshawih S; Goh HP; Kifli N; Idris AC; Yassin H; Kotra V; Goh KW; Liew KB; Ming LC
Chem Biol Drug Des; 2022 Aug; 100(2):185-217. PubMed ID: 35490393
[TBL] [Abstract][Full Text] [Related]
7. Introduction to artificial intelligence and deep learning using interactive electronic programming notebooks.
Menke J; Homberg S; Koch O
Arch Pharm (Weinheim); 2023 Jul; 356(7):e2200628. PubMed ID: 37066712
[TBL] [Abstract][Full Text] [Related]
8. Cheminformatics in Drug Discovery, an Industrial Perspective.
Chen H; Kogej T; Engkvist O
Mol Inform; 2018 Sep; 37(9-10):e1800041. PubMed ID: 29774657
[TBL] [Abstract][Full Text] [Related]
9. The challenges of generalizability in artificial intelligence for ADME/Tox endpoint and activity prediction.
Huang DZ; Baber JC; Bahmanyar SS
Expert Opin Drug Discov; 2021 Sep; 16(9):1045-1056. PubMed ID: 33739897
[TBL] [Abstract][Full Text] [Related]
10. Applications of artificial intelligence in drug development using real-world data.
Chen Z; Liu X; Hogan W; Shenkman E; Bian J
Drug Discov Today; 2021 May; 26(5):1256-1264. PubMed ID: 33358699
[TBL] [Abstract][Full Text] [Related]
11. Artificial Intelligence and Cancer Drug Development.
Yang F; Darsey JA; Ghosh A; Li HY; Yang MQ; Wang S
Recent Pat Anticancer Drug Discov; 2022; 17(1):2-8. PubMed ID: 34323201
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence in drug discovery: recent advances and future perspectives.
Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G
Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453
[No Abstract] [Full Text] [Related]
13. Artificial intelligence: Machine learning approach for screening large database and drug discovery.
Parvatikar PP; Patil S; Khaparkhuntikar K; Patil S; Singh PK; Sahana R; Kulkarni RV; Raghu AV
Antiviral Res; 2023 Dec; 220():105740. PubMed ID: 37935248
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
[TBL] [Abstract][Full Text] [Related]
15. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
16. Artificial Intelligence and Machine Learning for Lead-to-Candidate Decision-Making and Beyond.
McNair D
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():77-97. PubMed ID: 35679624
[TBL] [Abstract][Full Text] [Related]
17. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
Muller C; Rabal O; Diaz Gonzalez C
Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
[TBL] [Abstract][Full Text] [Related]
18. Unleashing the power of generative AI in drug discovery.
Gangwal A; Lavecchia A
Drug Discov Today; 2024 Jun; 29(6):103992. PubMed ID: 38663579
[TBL] [Abstract][Full Text] [Related]
19. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
[TBL] [Abstract][Full Text] [Related]
20. Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.
Cova T; Vitorino C; Ferreira M; Nunes S; Rondon-Villarreal P; Pais A
Methods Mol Biol; 2022; 2390():321-347. PubMed ID: 34731476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
